Research Articles | Page 6 | Aplastic Anemia & MDS International Foundation Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Why do we not have more drugs approved for MDS? A critical viewpoint on novel drug development in MDS Jul 2023 Blood Advances myelodysplastic syndromes (MDS)
Raising the bar for lower-risk myelodysplastic syndromes Jun 2023 Leukemia & Lymphoma myelodysplastic syndromes (MDS)
Nationwide study of eculizumab in paroxysmal nocturnal hemoglobinuria: Evaluation of treatment indications and outcomes Jun 2023 European Journal of Haematology paroxysmal nocturnal hemoglobinuria (PNH)
Complement Inhibition in Paroxysmal Nocturnal Hemoglobinuria (PNH): A Systematic Review and Expert Opinion from Central Europe on Special Patient Populations Jun 2023 Advances in Therapy paroxysmal nocturnal hemoglobinuria (PNH)
Alemtuzumab in relapsed immune severe aplastic anemia: Long-term results of a phase II study Jun 2023 American Journal of Hematology aplastic anemia
An agenda to advance research in myelodysplastic syndromes: a TOP 10 priority list from the first international workshop in MDS Jun 2023 Blood Advances myelodysplastic syndromes (MDS)
Clonal evolution in aplastic anemia: failed tumor surveillance or maladaptive recovery? Jun 2023 Leukemia & Lymphoma aplastic anemia
Determinants of low health-related quality of life in patients with myelodysplastic syndromes: EUMDS Registry study Jun 2023 Blood Advances myelodysplastic syndromes (MDS)
Therapy-related myelodysplastic syndromes in the genomics era Jun 2023 Bulletin du Cancer myelodysplastic syndromes (MDS)
Treatment of eculizumab refractory paroxysmal nocturnal hemoglobinuria: A systematic review about current treatment options and future direction Jun 2023 SAGE Open Medicine paroxysmal nocturnal hemoglobinuria (PNH)
Share with addtoany.com.